09/17/2015 07:37 am ET

Playing Down The Risks Of A Billion-Dollar Drug

By the beginning of 1999, Johnson & Johnson had expanded the ElderCare unit to 136 salespeople from 83, and the materials they were using to pitch doctors had caught the FDA’s eye.

Read more on HuffPost Highline